Antharis Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Antharis Therapeutics?

Antharis Therapeutics is funded by Fuse Capital.

Overview

Antharis Therapeutics

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Antharis Therapeutics

CB Rank

127219

Antharis Therapeutics is a biopharmaceutical company developing therapies for unmet medical needs.

Founded

obfuscation

Private

Seed

Vista, California, United States

11-50

antharistherapeutics.com/

Biopharma

Biotechnology

Therapeutics

Funding Rounds

Seed

OBF

obfuscation

Key People

Raphael Ribeiro Pinaud: Founder, Chairman & CEO

Details

Legal Name

Antharis Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Raphael Ribeiro Pinaud

Phone Number

1 234-765-8970

Contact Email

contact@antharistherapeutics.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Monoclonal Antibody Therapies

Therapeutic monoclonal antibodies designed to harness the immune system to treat various cancers and other unmet medical needs.

Antibody-Drug Conjugates (ADCs)

Therapies combining monoclonal antibodies with cytotoxic agents to target and kill cancer cells more precisely.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Antharis Therapeutics	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Antharis Therapeutics	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Antharis Therapeutics	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Antharis Therapeutics	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Antharis Therapeutics	1	obfuscated obfuscation	—	Seed

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Antharis Therapeutics	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Antharis Therapeutics	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Antharis Therapeutics	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Antharis Therapeutics	1	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Antharis Therapeutics	1	obfuscated obfuscation	—	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Fuse Capital	—	Seed Round - Antharis Therapeutics	—
Fuse Capital	—	Seed Round - Antharis Therapeutics	—
Fuse Capital	—	Seed Round - Antharis Therapeutics	—
Fuse Capital	—	Seed Round - Antharis Therapeutics	—
Fuse Capital	—	Seed Round - Antharis Therapeutics	—